Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Members of the Florida Keys mosquito control department inspecting a neighborhood in Key Largo in July 2020. Photo: Joe Raedle/Getty Images

Oxitec, a British startup determined to prevent instances of mosquito-borne disease, released thousands of genetically modified mosquito eggs in the Florida Keys this week as part of a test approved by the Environmental Protection Agency and Florida's agriculture department.

Why it matters: It marks the first release of genetically modified mosquitoes in the U.S. and has some locals worried about how this will impact the broader ecosystem, according to CNN.

How it works: Oxitec expects to target Aedes aegypti, an invasive species of mosquito that carries several dangerous diseases like yellow fever, dengue and Zika virus.

  • The startup aims to control the species by releasing genetically modified male mosquitoes that, like natural male Aedes aegypti, feed on nectar rather than blood and do not transmit diseases to humans.
  • The modified males carry a "self-limiting" gene that will target and kill future female Aedes aegypti, which feed on humans and can transmit dangerous diseases.
  • The company hopes that by releasing the modified males, it will lower the number of biting females and reduce instances of disease transmission.

By the numbers: Oxitec said that Aedes aegypti makes up just 4% of the mosquito population in the Keys but is responsible for virtually all disease transmission there.

  • The company has released more than 1 billion bugs around the world, including in Brazil and the Cayman Islands, Axios' Dan Primack reports.

What they're saying: "The challenges posed by disease-spreading mosquitoes is growing, not shrinking, making this pilot project a major step forward in bringing Oxitec’s safe, self-limiting technology to the [U.S.]," Grey Frandsen, Oxitec’s CEO, said in a statement.

  • “Our primary mission is to protect residents in the Florida Keys from all mosquitoes including the disease-transmitting Aedes aegypti," said Andrea Leal, executive director of the Florida Keys Mosquito Control District, which collaborated with Oxitec on the release project.

The big picture: If successful, the release of genetically modified males could become an alternative to controlling mosquito populations.

  • Currently, the primary way to control the populations is by spraying insecticides that can persist in the environment and unintentionally harm insects like bees and butterflies.
  • Yes, but: Some Florida Key residents have strongly opposed the release of genetically modified mosquitoes since the project was announced, according to CNN.

Go deeper

53 mins ago - Health

Study: Over 99% of hospitalized COVID-19 patients were not vaccinated

Photo: Joe Raedle/Getty Images

The Cleveland Clinic on Tuesday released a study showing that 99.75% of patients hospitalized with COVID-19 between Jan. 1 and April 13 were not fully vaccinated, according to data provided to Axios.

Why it matters: Real-world evidence continues to show coronavirus vaccines are effective at keeping people from dying and out of hospitals. The Pfizer-BioNTech and Moderna vaccines have been found to be 95% and 94% effective, respectively, at preventing symptomatic infections.

2 hours ago - Health

Biden reaches agreements with Uber and Lyft to give free rides to vaccine sites

The Biden administration has reached agreements with ride-sharing companies Uber and Lyft to offer free rides to coronavirus vaccination sites through July 4, the White House announced Tuesday.

Why it matters: The free rides, starting in the next two weeks, are part of the Biden administration's push to administer at least one vaccine dose to 70% of U.S. adults by Independence Day.

Ben Geman, author of Generate
3 hours ago - Energy & Environment

Biden officials green-light nation's first big offshore wind project

Illustration: Aïda Amer/Axios. Photo by Brendan Smialowski/AFP via Getty Images

The Biden administration today gave final approval to Vineyard Wind, a project off the Massachusetts coast slated to be the country's first large-scale offshore wind farm.

Why it matters: While the green light for the long-proposed project was expected, it marks a key step in White House plans to help spur development of a suite of coastal projects off New York, New Jersey and other states.